Dashboard
Manage Tickers

NOVT NOVANTA INC

Nasdaq novanta.com


$ 128.66 $ 9.83 (8.27 %)    

Friday, 24-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 128.65
$ 120.00
$ 112.50 x 20
$ 130.99 x 16
$ 120.00 - $ 130.97
$ 98.76 - $ 184.11
1,064,595
na
4.63B
$ 1.50
$ 75.42
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-27-2025 10-Q
2 05-06-2025 03-28-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-05-2024 09-27-2024 10-Q
5 08-06-2024 06-28-2024 10-Q
6 05-07-2024 03-29-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-07-2023 09-29-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 07-01-2022 10-Q
14 05-10-2022 04-01-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 10-01-2021 10-Q
17 08-10-2021 07-02-2021 10-Q
18 05-11-2021 04-02-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-10-2020 10-02-2020 10-Q
21 08-06-2020 07-03-2020 10-Q
22 05-12-2020 04-03-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-05-2019 09-27-2019 10-Q
25 08-06-2019 06-28-2019 10-Q
26 05-07-2019 03-29-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-06-2018 09-28-2018 10-Q
29 08-08-2018 06-29-2018 10-Q
30 05-08-2018 03-30-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 11-01-2017 09-29-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-08-2017 03-31-2017 10-Q
35 03-06-2017 12-31-2016 10-K
36 11-02-2016 09-30-2016 10-Q
37 08-02-2016 07-01-2016 10-Q
38 05-06-2016 04-01-2016 10-Q
39 03-02-2016 12-31-2015 10-K
40 11-04-2015 10-02-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novanta-board-authorizes-repurchase-of-up-to-addl-200m-of-outstanding-common-shares-adding-capacity-to-31m-remaining-from-2020-board-authorization-for-total-capacity-of-231m
Novanta Board Authorizes Repurchase Of Up ...
09/18/2025 12:07:15

Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment m...

baird-maintains-neutral-on-novanta-lowers-price-target-to-133
Baird Maintains Neutral on Novanta, Lowers...
08/11/2025 12:52:15

Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Neutral and lowers the price target from $139 to $133.

novanta-lowers-fy2025-adj-eps-guidance-from-335-355-to-322-336-vs-337-est-lowers-fy2025-sales-guidance-from-1000b-to-970000m-985000m-vs-983167m-est
Novanta Lowers FY2025 Adj EPS Guidance fro...
08/05/2025 10:58:57

Novanta (NASDAQ:NOVT) lowers FY2025 Adj EPS guidance from $3.35-$3.55 to $3.22-$3.36 vs $3.37 analyst estimate. Lowers FY2025 s...

novanta-sees-q3-adj-eps-078-085-vs-093-est-sees-sales-244000m-247000m-vs-254563m-est
Novanta Sees Q3 Adj EPS $0.78-$0.85 vs $0....
08/05/2025 10:58:04

Novanta (NASDAQ:NOVT) is looking for Q3 Adj EPS of $0.78-$0.85 vs $0.93 analyst estimate. sees sales of $244.000 million-$247.0...

novanta-q2-adj-eps-076-beats-073-estimate-sales-241049m-beat-237987m-estimate
Novanta Q2 Adj. EPS $0.76 Beats $0.73 Esti...
08/05/2025 10:56:38

Novanta (NASDAQ:NOVT) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.73 by 3.68...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

novanta-sees-q2-adj-eps-068-078-vs-075-est-sees-sales-230000m-240000m-vs-24074m-est
Novanta Sees Q2 Adj EPS $0.68-$0.78 vs $0....
05/06/2025 11:11:38

novanta-q1-adj-eps-074-beats-067-estimate-sales-23337m-beat-23334m-estimate
Novanta Q1 Adj. EPS $0.74 Beats $0.67 Esti...
05/06/2025 11:01:08

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

baird-maintains-neutral-on-novanta-lowers-price-target-to-160
Baird Maintains Neutral on Novanta, Lowers...
03/03/2025 12:52:48

Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Neutral and lowers the price target from $169 to $160.

Core News & Articles
Identiv Enters Strategic Business Developm...
02/27/2025 12:23:07

The partnership aims to streamline the adoption of intelligent, RFID-enabled solutions for medical device OEMs by combining Ide...

novanta-expects-fy25-revenue-of-1b-vs-104b-est-adj-eps-of-335-355-vs-379-est
Novanta Expects FY25 Revenue Of ~$1B Vs $1...
02/25/2025 12:09:38

For the full year 2025, the Company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approxim...

novanta-expects-q1-revenue-of-232m-236m-vs-24489m-est-adj-eps-of-063-071-vs-078-est
Novanta Expects Q1 Revenue Of $232M-$236M ...
02/25/2025 12:05:34

For the full year 2025, the Company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approxim...

novanta-q4-2024-adj-eps-076-beats-071-estimate-sales-238060m-miss-240287m-estimate
Novanta Q4 2024 Adj. EPS $0.76 Beats $0.71...
02/25/2025 12:01:33

earnings-scheduled-for-february-25-2025
Earnings Scheduled For February 25, 2025
02/25/2025 08:32:24

baird-maintains-neutral-on-novanta-lowers-price-target-to-169
Baird Maintains Neutral on Novanta, Lowers...
11/06/2024 12:44:13

Baird analyst Robert Mason maintains Novanta (NASDAQ:NOVT) with a Neutral and lowers the price target from $175 to $169.

novanta-expects-fy24-revenue-of-948m-953m-prior-975m-vs-97308m-est-adj-eps-of-302-306-prior-320-335-vs-329-est
Novanta Expects FY24 Revenue Of $948M-$953...
11/05/2024 12:08:19

For the full year 2024, the Company expects GAAP revenue of approximately $948 million to $953 million. The Company expects Adj...

novanta-expects-q4-revenue-of-237m-242m-vs-24233m-est-adj-eps-of-070-074-vs-085-est
Novanta Expects Q4 Revenue Of $237M-$242M ...
11/05/2024 12:04:47

For the fourth quarter of 2024, the Company expects GAAP revenue of approximately $237 million to $242 million. The Company exp...

novanta-q3-2024-adj-eps-085-inline-sales-244405m-beat-242327m-estimate
Novanta Q3 2024 Adj. EPS $0.85, Inline, Sa...
11/05/2024 12:00:17

looking-into-novantas-recent-short-interest
Looking Into Novanta's Recent Short Interest
08/29/2024 17:45:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION